Developing a prototype virtual reality experience of home environments that foster health and wellness for those living with diabetes: a step towards health equity.
Ended Definitive Contract Awarded Last action
- Contract number
- 75F40124C00047
- Awardee
-
HKS Inc. UEI EU9MKWVA1TF8
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,254,904
Award facts
- Contract value 100% obligated
- $1,254,903.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Dallas, TX 75201, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Additional Work (new agreement, FAR part 6 applies) | $65,000 | |
| Original award | $1,189,904 |
About this award
The U.S. Food and Drug Administration (FDA) awarded a $1,254,903.56 firm fixed price contract to HKS Inc., doing business as HKS Architects, to develop a prototype virtual reality (VR) experience of home environments that foster health and wellness for individuals living with diabetes. This contract is a step towards promoting health equity through innovative design solutions. HKS Architects is a global architecture and design firm that has a significant contract history with the U.S. government, including providing program management, planning, design, and construction management support services for the Kingdom of Saudi Arabia Ministry of Defense Transformation Initiative under a $700 million indefinite delivery/indefinite quantity (ID/IQ) contract with the U.S. Army Corps of Engineers Engineering District Middle East. This contract award does not have a set-aside designation.
Quick answers
Who was awarded contract 75F40124C00047?
75F40124C00047 was awarded to HKS Inc. by Food and Drug Administration (Department of Health and Human Services) on April 5, 2024.
How much is contract 75F40124C00047 worth?
The government has obligated $1,254,904 on 75F40124C00047.
Was contract 75F40124C00047 competed?
The extent of competition for 75F40124C00047 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award